# The LIVMOR Data Collection Study for the Development and Validation of L-1000AF System

Study · id `cardio:ct-nct04104191` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04104191](<https://clinicaltrials.gov/study/NCT04104191>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04104191

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 271 participants.

## Technical summary

Registry record NCT04104191. Allocation not applicable; no masking; primary purpose screening. Start 2017-07-27 (actual); primary completion 2019-02-13 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose screening
- Phase: Not applicable
- Enrolled: 271 participants (enrolled count; ClinicalTrials.gov record NCT04104191, source copy `cardio:ctgov-nct04104191-2019-09-26`, retrieved 2026-10-26)
- Started: 2017-07-27 (actual) (ClinicalTrials.gov record NCT04104191, source copy `cardio:ctgov-nct04104191-2019-09-26`, retrieved 2026-10-26)
- Primary completion: 2019-02-13 (actual) (ClinicalTrials.gov record NCT04104191, source copy `cardio:ctgov-nct04104191-2019-09-26`, retrieved 2026-10-26)
- Completion: 2019-02-14 (actual) (ClinicalTrials.gov record NCT04104191, source copy `cardio:ctgov-nct04104191-2019-09-26`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04104191, source copy `cardio:ctgov-nct04104191-2019-09-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04104191-2019-09-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: The LIVMOR Data Collection Study for the Development and Validation of L-1000AF System
- Condition: Atrial Fibrillation
- Intervention (Device): L-1000AF System
- Lead sponsor: LIVMOR, Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: Texas Health Dallas
- Collaborator class: UNKNOWN
- Collaborator: North Texas Veterans Healthcare System
- Collaborator class: FED

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as a collaborator: North Texas Veterans Healthcare System (`cardio:org-north-texas-veterans-healthcare-system`)

## Provenance

Content hash: 89352b176e534d63a44e319bc4189fb56d0e7a78d0b4150fe96c08e2eae75864
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
